Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 06 Mar 2023
USA: The syrup drug Diethylene glycol (DEG), a drug commonly used to prevent infections, is the cause of kidney disease...
Read Full NewsExplore the evolving landscape of developmental and epileptic encephalopathies in adults, highlighting precision therapies and the need for accurate diagnoses.
Explore the transformative buzzwords in neurology for 2025, highlighting advancements in AI, gene therapy, personalized treatment, and neuroplasticity.
1.
Daily physical activity, even at light intensities, linked to lower cancer risk
2.
Routine breast cancer screening can bring better outcomes for patients
3.
For some patients with bladder cancer that has invaded the muscle, trimodality therapy is just as effective as radical cystectomy.
4.
Kate Middleton and Remission: Oncologists Weigh In
5.
Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma
1.
Mastering Surgical Oncology: Education, Certification, Trials, and Therapy Insights
2.
Advancing Cancer Care: Insights into Oncology Trials, Immunotherapy, and CAR-T Innovations
3.
Recent Advances in Paroxysmal Nocturnal Hemoglobinuria Research: Promising Therapies on the Horizon
4.
Seeing the Unseen: The Benefits of Early Stage Breast Cancer Ultrasound
5.
The Miracle of Thyrogen Injection: A New Hope for Thyroid Cancer Treatment
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge